company background image
NVSE.F logo

Novartis OTCPK:NVSE.F Stock Report

Last Price

US$96.39

Market Cap

US$211.0b

7D

-3.6%

1Y

16.5%

Updated

25 Mar, 2024

Data

Company Financials +

NVSE.F Stock Overview

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally.

NVSE.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health5/6
Dividends4/6

Novartis AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Novartis
Historical stock prices
Current Share PriceCHF96.39
52 Week HighCHF109.00
52 Week LowCHF88.50
Beta0.46
1 Month Change-7.18%
3 Month Change-1.94%
1 Year Change16.50%
3 Year Change13.60%
5 Year Change0.28%
Change since IPO139.48%

Recent News & Updates

Recent updates

Shareholder Returns

NVSE.FUS PharmaceuticalsUS Market
7D-3.6%-0.06%2.1%
1Y16.5%23.6%30.4%

Return vs Industry: NVSE.F underperformed the US Pharmaceuticals industry which returned 23.6% over the past year.

Return vs Market: NVSE.F underperformed the US Market which returned 30.4% over the past year.

Price Volatility

Is NVSE.F's price volatile compared to industry and market?
NVSE.F volatility
NVSE.F Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.0%

Stable Share Price: NVSE.F has not had significant price volatility in the past 3 months.

Volatility Over Time: NVSE.F's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199676,057Vas Narasimhanhttps://www.novartis.com

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology.

Novartis AG Fundamentals Summary

How do Novartis's earnings and revenue compare to its market cap?
NVSE.F fundamental statistics
Market capUS$210.96b
Earnings (TTM)US$8.57b
Revenue (TTM)US$46.66b

24.6x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NVSE.F income statement (TTM)
RevenueUS$46.66b
Cost of RevenueUS$12.02b
Gross ProfitUS$34.64b
Other ExpensesUS$26.07b
EarningsUS$8.57b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 23, 2024

Earnings per share (EPS)3.91
Gross Margin74.24%
Net Profit Margin18.36%
Debt/Equity Ratio52.6%

How did NVSE.F perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

95%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.